The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...
A man in his 40s experienced "asymptomatic yellowish nodules on his palms, soles, and elbows" for three weeks.
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli, or chenodiol, to treat Cerebrotendinous Xanthoma, the agency said Friday. "FDA Approves Mirum Pharmaceuticals Treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results